These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2240497)

  • 1. Clinical presentation of suspected malignant hyperthermia during anaesthesia in 402 probands.
    Ellis FR; Halsall PJ; Christian AS
    Anaesthesia; 1990 Oct; 45(10):838-41. PubMed ID: 2240497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a relationship between masseteric muscle spasm and malignant hyperpyrexia?
    Christian AS; Ellis FR; Halsall PJ
    Br J Anaesth; 1989 May; 62(5):540-4. PubMed ID: 2730825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated masseter muscle spasm and increased creatine kinase without malignant hyperthermia susceptibility or other myopathies.
    Kaplan RF; Rushing E
    Anesthesiology; 1992 Oct; 77(4):820-2. PubMed ID: 1416181
    [No Abstract]   [Full Text] [Related]  

  • 4. Masseter muscle spasm and the diagnosis of malignant hyperthermia susceptibility.
    Ellis FR; Hopkins PM; Halsall PJ; Christian AS
    Anesth Analg; 1992 Jul; 75(1):143-6. PubMed ID: 1616144
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle.
    Britt BA
    N Engl J Med; 1974 May; 290(20):1140-2. PubMed ID: 4274465
    [No Abstract]   [Full Text] [Related]  

  • 6. Muscle changes in malignant hyperthermia.
    Hausman R
    J Pathol; 1973 Jul; 110(3):Pv-vi. PubMed ID: 4744080
    [No Abstract]   [Full Text] [Related]  

  • 7. Myoglobinuria versus hemoglobinuria.
    Materson BJ; Preston RA
    Hosp Pract (Off Ed); 1988 Oct; 23(10A):29-38. PubMed ID: 3141436
    [No Abstract]   [Full Text] [Related]  

  • 8. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
    O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE
    Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant hyperthermia. I. Observations in connection with its pathogenesis and course (author's transl)].
    Plötz J; Braun J; Gericke B
    Anaesthesist; 1980 Feb; 29(2):89-93. PubMed ID: 7377528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden death due to malignant hyperthermia.
    Pamukcoglu T
    Am J Forensic Med Pathol; 1988 Jun; 9(2):161-2. PubMed ID: 3381797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extra-cardial rise of the CPK in the screening of urgent diagnostic (among others, a case of anaesthesia induced myoglobinuria and a case of malignant hypertermia) (author's transl)].
    Bernhardt D; Hörder MH
    Med Klin; 1977 Nov; 72(46):1967-71. PubMed ID: 927298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Masseter spasm with anesthesia: incidence and implications.
    Schwartz L; Rockoff MA; Koka BV
    Anesthesiology; 1984 Dec; 61(6):772-5. PubMed ID: 6507932
    [No Abstract]   [Full Text] [Related]  

  • 13. The work of the Leeds Malignant Hyperpyrexia Unit, 1971-84.
    Ellis FR; Halsall PJ; Harriman DG
    Anaesthesia; 1986 Aug; 41(8):809-15. PubMed ID: 3752463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central core disease and malignant hyperthermia syndrome.
    Frank JP; Harati Y; Butler IJ; Nelson TE; Scott CI
    Ann Neurol; 1980 Jan; 7(1):11-7. PubMed ID: 7362206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of malignant hyperthermia susceptibility. 2. Anesthesia for muscle biopsy. Differential diagnosis in negative test results].
    Breucking E; Mortier W
    Anaesthesist; 1993 Oct; 42(10):684-90. PubMed ID: 8250202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of malignant hyperpyrexia.
    Br Med J; 1973 Feb; 1(5848):249. PubMed ID: 4685313
    [No Abstract]   [Full Text] [Related]  

  • 17. Should we use muscle biopsy to diagnose malignant hyperthermia susceptibility?
    Larach MG
    Anesthesiology; 1993 Jul; 79(1):1-4. PubMed ID: 8342796
    [No Abstract]   [Full Text] [Related]  

  • 18. Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility?
    Flewellen EH; Nelson TE
    Anesth Analg; 1984 Jul; 63(7):693-7. PubMed ID: 6731899
    [No Abstract]   [Full Text] [Related]  

  • 19. Adrenal cortical reserve in patients undergoing muscle biopsy for malignant hyperthermia screening.
    Fairbrass MJ; Coe P; Ellis FR
    Br J Anaesth; 1989 Jan; 62(1):66-9. PubMed ID: 2917113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Masseter spasm and elevated creatine kinase after intravenous induction in a child.
    Habre W; Sims C
    Anaesth Intensive Care; 1996 Aug; 24(4):496-9. PubMed ID: 8862651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.